Tender

Provision of Combined IgG/IgM Elisa kits

  • Public Health England

F02: Contract notice

Notice identifier: 2021/S 000-001285

Procurement identifier (OCID): ocds-h6vhtk-028c5b

Published 21 January 2021, 11:08pm



Section one: Contracting authority

one.1) Name and addresses

Public Health England

Manor Farm Road, Porton Down

Salisbury

SP2 0QT

Email

Mercy.Mashem@phe.gov.uk

Telephone

+44 2076548000

Country

United Kingdom

NUTS code

UK - UNITED KINGDOM

Internet address(es)

Main address

https://phe.bravosolution.co.uk

one.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at

https://phe.bravosolution.co.uk/esop/guest/go/opportunity/detail?opportunityId=50514

Additional information can be obtained from the above-mentioned address

Tenders or requests to participate must be submitted electronically via

https://phe.bravosolution.co.uk/esop/guest/go/opportunity/detail?opportunityId=50514

Tenders or requests to participate must be submitted to the above-mentioned address

one.4) Type of the contracting authority

National or federal Agency/Office

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Provision of Combined IgG/IgM Elisa kits

two.1.2) Main CPV code

  • 33141625 - Diagnostic kits

two.1.3) Type of contract

Supplies

two.1.4) Short description

Public Health England (PHE) is seeking to procure a Borrelia combined IgG/IgM ELISA suitable for screening Human Sera (and potentially CSF) from suspected Lyme disease patients.

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

Rare and Imported Pathogens Laboratory (RIPL) PHE Porton, is the UK clinical diagnostic laboratory for imported and rare bacterial and viral infections. This includes the UK Lyme disease reference service and the aim of this tender is to get a combined Borrelia ELISA IgG/IgM suitable for screening Human Sera (and potentially CSF) from suspected Lyme disease patients.

Should you wish to participate in this tender, please log into the bravo e-sourcing platform site or contact Mercy.Mashem@phe.gov.uk before the 29th of January, 2021.

two.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

12

This contract is subject to renewal

Yes

Description of renewals

Possibility of extension for a further 3 periods of 12 months, reviewed annually.

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Open procedure

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

four.2) Administrative information

four.2.2) Time limit for receipt of tenders or requests to participate

Date

29 January 2021

Local time

5:00pm

four.2.4) Languages in which tenders or requests to participate may be submitted

English

four.2.7) Conditions for opening of tenders

Date

22 February 2021

Local time

12:00pm


Section six. Complementary information

six.1) Information about recurrence

This is a recurrent procurement: No

six.4) Procedures for review

six.4.1) Review body

Public Health England

Manor Farm Road, Porton Down

Salisbury

Country

United Kingdom